Study finds a better way to detect heart disease in women
Although heart diseases might widely be known as 'man's disease', recent research has revealed that heart-related diseases are the leading cause of death in women.
While men may be at higher risk for heart disease and heart attacks at a younger age, heart disease is a significant health concern for both men and women. Moreover, while women are as likely to have a heart attack as men, they are more likely to die from one.
In fact, cardiovascular disease (CVD), including heart attacks, globally, is responsible for 35% of all female deaths.
Although the
recent research
might trigger a sense of panic, the better news is – a new study has emerged to show that using personalized heart wall measurements leads to more accurate hypertrophic cardiomyopathy diagnoses, especially in women.
What does the study say?
People with hidden heart conditions may be at risk because current medical guidelines overlook important personal differences. This new study, recently published in the
Journal of the American College of Cardiology
, is questioning an outdated standard for diagnosing heart disease that often goes unnoticed until it is too late.
Hypertrophic cardiomyopathy (HCM) affects about one in every 500 people. It can lead to dangerous heart rhythms, sudden cardiac arrest, and even death. This genetic condition thickens the heart muscle, making it harder for the heart to pump blood. For years, doctors diagnosed HCM based on one measurement: if the left ventricle wall is 15 millimeters thick or more, it is considered abnormal.
While this method has saved lives, scientists are now highlighting its flaws. A recent study shows that this fixed threshold may leave many people undiagnosed, particularly women and smaller individuals.
How current guidelines leave gaps:
HCM is usually diagnosed by measuring the thickness of the wall in the heart's main pumping chamber. For 50 years, the guideline has remained the same: a wall thicker than 15 millimeters may indicate HCM. This cutoff does not change based on age, sex, or body size, which is a problem. Not all hearts are the same size. Women typically have smaller hearts, so a thickened wall in a smaller heart might not reach the 15-millimeter mark, even if the person has HCM. Men, who generally have larger hearts, might meet the threshold even if they do not have the disease.
Data supports this concern. Currently, two out of three people diagnosed with HCM are men. However, researchers believe that men and women are equally likely to have the disease, and women may be overlooked by an outdated system.
Dr. Hunain Shiwani, who led the study at the UCL Institute of Cardiovascular Science, said, 'This threshold, based on studies from the 1970s, needs to be reconsidered. Using the same cutoff for everyone, regardless of age, sex, or size, ignores how these factors strongly influence heart wall thickness.'
Personalized method to ensure better accuracy:
To address this issue, researchers developed a smarter, more individual approach. They used artificial intelligence to study over 5,000 MRI heart scans from healthy individuals. The AI measured heart wall thickness in people of different ages, sexes, and body sizes. From this, they created a range of normal values that reflect actual differences in heart structure.
Instead of a single number, the new method adjusts the threshold based on a person's profile. For example, older or larger people might have a higher cutoff, while younger, smaller people, including many women, would have a lower one.
When researchers tested this updated method on 1,600 patients already diagnosed with HCM, they saw significant improvements. Among women, detection rates increased by 20 percentage points. This means that one in five women who would have been missed before are now recognized as having the disease.
Dr. Shiwani added, 'Our research provides a much-needed update, showing that a personalized approach improves diagnosis accuracy. Effective treatments for HCM are starting to be used for the first time, making it crucial to correctly identify those who need them.'
The new guidelines:
Researchers applied new and old methods to check for hypertrophic cardiomyopathy (HCM) in over 43,000 people from a health database. Using the old method, only one in eight people flagged as possibly having HCM was a woman. The flagged individuals were usually older, taller, and heavier than average.
With the new personalized approach, the number of flagged cases actually decreased, which means fewer false positives. Importantly, nearly half of those identified (44%) were women, which aligns better with the fact that HCM affects both men and women equally.
The goal is not only to find more cases but also to avoid mistakes. A wrong diagnosis can change someone's life by leading to unnecessary tests, anxiety, or medication. Dr. Sonya Babu-Narayan from the British Heart Foundation highlighted the importance of preventing misdiagnoses. She said, 'A diagnosis changes lives, so we should work hard to avoid misdiagnosing people.'
By updating the old approach, this study redefines what is considered abnormal heart wall thickness, a key factor in diagnosing HCM. This change helps identify more women and smaller individuals who might otherwise be overlooked.
The way forward:
The research findings are available online in the Journal of the American College of Cardiology. This research could greatly change how doctors identify and treat HCM worldwide. The scientists want to ensure that the new guidelines also work with echocardiograms, as these are more commonly used in clinics than MRIs. They are also exploring ways to include other important factors, such as race and ethnicity, in future diagnostic tools. The aim is to help doctors make better decisions for every patient, regardless of their shape or size.
The research team hopes that heart specialists in Europe and North America will adopt these updated guidelines soon. Personalized thresholds could become standard, leading to fairer and more accurate diagnoses.
Dr. Babu-Narayan concluded, 'This more personalized approach to defining abnormal heart muscle thickness marks a new era for accurate diagnosis for patients and families affected by hypertrophic cardiomyopathy.'
Study finds how female, male hearts respond differently to stress hormone
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
2 hours ago
- The Hindu
After 18-year battle with genetic heart disease, 41-year-old Bengaluru resident gets transplant
For 18 long years, life for a 41-year-old Bengaluru resident was a battle against a failing heart. Diagnosed with a genetically inherited cardiomyopathy in his early twenties, his struggle of nearly two decades ended with a life-saving heart transplant at a private hospital in the city. A marketing manager by profession, Mohammed Rafi — who hails from Kerala — was diagnosed with Hypertrophic Cardiomyopathy (HCM) at the age of 23, a disease that has been running in his family for ages. From then on, his life took an unexpected turn from being unable to go to gym and or play in cricket tournaments to a daily battle for survival. Runs in family His mother, sister, grandmother, uncle, cousin, and even his young daughter had the same condition. However, it was not until his daughter passed away, at the age of four, that they began to explore the genetic factor. Doctors at Manipal Hospital Old Airport Road, where the transplant was done, said the patient, who otherwise led an active life, experienced unusual fatigue while playing cricket during an office excursion. However, he ignored it to be a normal consequence of skipping breakfast. Other symptoms of dizziness, breathlessness, and bloating persisted for days. Worried about this sudden change in his health, he visited a doctor in Kerala, only to discover that he was in the early stages of HCM — a serious, often hereditary condition where the heart muscle becomes abnormally thick. Although he continued to lead a normal life, the physical toll began to affect his professional and personal life over time. 'Because my job included business travel to different places, I had to ask people to help push my bike through traffic. At one point, I realised I could not even lift my laptop,' he said. Initially treated by Sridhara G, Consultant - Interventional Cardiology and Cardiac Electrophysiology at Manipal Hospital Old Airport Road, for over a decade, he underwent the implantation of an AICD (Automated Implantable Cardioverter Defibrillator). While this intervention gave some relief for a couple of years, his health gradually worsened with symptoms, such as swelling in the body, constant fatigue, and reduced mobility. This was when he was diagnosed with heart failure, with a heart transplantation being the last resort. Wait for organ donors The waiting period for a heart transplant was lengthy, with a severe shortage of compatible organ donors. Registered on the transplant list since 2019, it was only three months ago that he finally underwent the transplant, on March 21, 2025. A team of doctors led by Devananda N.S., HOD and Consultant – Cardiothoracic Vascular Surgery, and Heart and Lung Transplant Surgery, conducted the surgery. After two weeks of hospital stay, he was discharged on April 5, 2025. His recovery process is still ongoing, with doctors anticipating another 3-4 months for full recovery. 'If families like Mr. Rafi's are screened early, disease modification to some extent is possible, and other asymptomatic members of the family can also be helped. This is high time we work on creating a national genetic database on such rare cardiac disorders,' said Dr. Devananda.
Time of India
27-04-2025
- Time of India
Study finds a better way to detect heart disease in women
Although heart diseases might widely be known as 'man's disease', recent research has revealed that heart-related diseases are the leading cause of death in women. While men may be at higher risk for heart disease and heart attacks at a younger age, heart disease is a significant health concern for both men and women. Moreover, while women are as likely to have a heart attack as men, they are more likely to die from one. In fact, cardiovascular disease (CVD), including heart attacks, globally, is responsible for 35% of all female deaths. Although the recent research might trigger a sense of panic, the better news is – a new study has emerged to show that using personalized heart wall measurements leads to more accurate hypertrophic cardiomyopathy diagnoses, especially in women. What does the study say? People with hidden heart conditions may be at risk because current medical guidelines overlook important personal differences. This new study, recently published in the Journal of the American College of Cardiology , is questioning an outdated standard for diagnosing heart disease that often goes unnoticed until it is too late. Hypertrophic cardiomyopathy (HCM) affects about one in every 500 people. It can lead to dangerous heart rhythms, sudden cardiac arrest, and even death. This genetic condition thickens the heart muscle, making it harder for the heart to pump blood. For years, doctors diagnosed HCM based on one measurement: if the left ventricle wall is 15 millimeters thick or more, it is considered abnormal. While this method has saved lives, scientists are now highlighting its flaws. A recent study shows that this fixed threshold may leave many people undiagnosed, particularly women and smaller individuals. How current guidelines leave gaps: HCM is usually diagnosed by measuring the thickness of the wall in the heart's main pumping chamber. For 50 years, the guideline has remained the same: a wall thicker than 15 millimeters may indicate HCM. This cutoff does not change based on age, sex, or body size, which is a problem. Not all hearts are the same size. Women typically have smaller hearts, so a thickened wall in a smaller heart might not reach the 15-millimeter mark, even if the person has HCM. Men, who generally have larger hearts, might meet the threshold even if they do not have the disease. Data supports this concern. Currently, two out of three people diagnosed with HCM are men. However, researchers believe that men and women are equally likely to have the disease, and women may be overlooked by an outdated system. Dr. Hunain Shiwani, who led the study at the UCL Institute of Cardiovascular Science, said, 'This threshold, based on studies from the 1970s, needs to be reconsidered. Using the same cutoff for everyone, regardless of age, sex, or size, ignores how these factors strongly influence heart wall thickness.' Personalized method to ensure better accuracy: To address this issue, researchers developed a smarter, more individual approach. They used artificial intelligence to study over 5,000 MRI heart scans from healthy individuals. The AI measured heart wall thickness in people of different ages, sexes, and body sizes. From this, they created a range of normal values that reflect actual differences in heart structure. Instead of a single number, the new method adjusts the threshold based on a person's profile. For example, older or larger people might have a higher cutoff, while younger, smaller people, including many women, would have a lower one. When researchers tested this updated method on 1,600 patients already diagnosed with HCM, they saw significant improvements. Among women, detection rates increased by 20 percentage points. This means that one in five women who would have been missed before are now recognized as having the disease. Dr. Shiwani added, 'Our research provides a much-needed update, showing that a personalized approach improves diagnosis accuracy. Effective treatments for HCM are starting to be used for the first time, making it crucial to correctly identify those who need them.' The new guidelines: Researchers applied new and old methods to check for hypertrophic cardiomyopathy (HCM) in over 43,000 people from a health database. Using the old method, only one in eight people flagged as possibly having HCM was a woman. The flagged individuals were usually older, taller, and heavier than average. With the new personalized approach, the number of flagged cases actually decreased, which means fewer false positives. Importantly, nearly half of those identified (44%) were women, which aligns better with the fact that HCM affects both men and women equally. The goal is not only to find more cases but also to avoid mistakes. A wrong diagnosis can change someone's life by leading to unnecessary tests, anxiety, or medication. Dr. Sonya Babu-Narayan from the British Heart Foundation highlighted the importance of preventing misdiagnoses. She said, 'A diagnosis changes lives, so we should work hard to avoid misdiagnosing people.' By updating the old approach, this study redefines what is considered abnormal heart wall thickness, a key factor in diagnosing HCM. This change helps identify more women and smaller individuals who might otherwise be overlooked. The way forward: The research findings are available online in the Journal of the American College of Cardiology. This research could greatly change how doctors identify and treat HCM worldwide. The scientists want to ensure that the new guidelines also work with echocardiograms, as these are more commonly used in clinics than MRIs. They are also exploring ways to include other important factors, such as race and ethnicity, in future diagnostic tools. The aim is to help doctors make better decisions for every patient, regardless of their shape or size. The research team hopes that heart specialists in Europe and North America will adopt these updated guidelines soon. Personalized thresholds could become standard, leading to fairer and more accurate diagnoses. Dr. Babu-Narayan concluded, 'This more personalized approach to defining abnormal heart muscle thickness marks a new era for accurate diagnosis for patients and families affected by hypertrophic cardiomyopathy.' Study finds how female, male hearts respond differently to stress hormone
Hans India
26-04-2025
- Hans India
AI algorithm can help identify high-risk heart patients: Study
New Delhi: A team of US researchers, studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) said they have calibrated an artificial intelligence (AI) algorithm to quickly and more specifically identify patients with the condition and flag them as high risk for greater attention during doctor's appointments. The algorithm, known as Viz HCM, had previously been approved by the Food and Drug Administration (FDA) for the detection of HCM on an electrocardiogram (ECG). The Mount Sinai study, published in the journal NEJM AI, assigns numeric probabilities to the algorithm's findings. For example, while the algorithm might previously have said 'flagged as suspected HCM' or 'high risk of HCM,' the Mount Sinai study allows for interpretations such as, 'You have about a 60 percent chance of having HCM,' said Joshua Lampert, Director of Machine Learning at Mount Sinai Fuster Heart Hospital. As a result, patients who had not previously been diagnosed with HCM may be able to get a better understanding of their individual disease risk, leading to a faster and more individualized evaluation, along with treatment to potentially prevent complications such as sudden cardiac death, especially in young patients. 'This is an important step forward in translating novel deep-learning algorithms into clinical practice by providing clinicians and patients with more meaningful information. Clinicians can improve their clinical workflows by ensuring the highest-risk patients are identified at the top of their clinical work list using a sorting tool,' said Lampert, Assistant Professor of Medicine (Cardiology, and Data-Driven and Digital Medicine) at the Icahn School of Medicine at Mount Sinai. HCM impacts one in 200 people worldwide and is a leading reason for heart transplantation. However, many patients don't know they have the condition until they have symptoms and the disease may already be advanced. 'This study reflects pragmatic implementation science at its best, demonstrating how we can responsibly and thoughtfully integrate advanced AI tools into real-world clinical workflows,' said co-senior author Girish N Nadkarni, Chair of the Windreich Department of Artificial Intelligence and Human Health and Director of the Hasso Plattner Institute for Digital Health.
